May Kung Sutherland - Concepedia

Concepedia

Author

May Kung Sutherland

University of Toronto

Also Known As

M K Sutherland, M Sutherland, M. K. Sutherland, M. Kung Dr. Sutherland, M. Kung Sutherland, M. Sutherland, M.K. Sutherland, M.Kung Sutherland, May K. Sutherland, May Kung SUTHERLAND

57

Publications

1.6K

Citations

19

H-Index

64

Concepts

All Affiliations

University of Toronto Seagen (United States)Toronto General Hospital Target (United States)St. Michael's Hospital

MK

About

May Kung Sutherland is an author at University of Toronto specializing in medicine, cell biology, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	819
2	Cell Biology	7	7	418
3	Health Sciences	2	2	60
4	Biochemistry	2	2	60
5	Natural Sciences	1	1	22

May Kung Sutherland

×

22

Publications

1.6K

Citations

19

H-Index

	Year	Citations
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers Leia M. Smith, Albina Nesterova, Maureen C. Ryan, British Journal of Cancer	2008	285
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation May Kung Sutherland, James C. Geoghegan, Changpu Yu, Bone Tissue EngineeringSclerostinBone Morphogenic ProteinNovel RegulationCell Death	2004	236
Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels May Kung Sutherland, Martin J. Somerville, Larry K.K. Yoong, Molecular Brain Research Alzheimer's DiseaseMedicineDementiaNeuropharmacologyDegenerative Pathology	1992	196
Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex David G. Winkler, Changpu Yu, James C. Geoghegan, Journal of Biological Chemistry	2004	105
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia Fu Li, May Kung Sutherland, Changpu Yu, Molecular Cancer Therapeutics	2017	94
Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75 Maureen C. Ryan, Heather Kostner, Karen A. Gordon, British Journal of Cancer	2010	85
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts May Kung Sutherland, James C. Geoghegan, Changpu Yu, Bone Regenerative MedicineSclerostinDevelopmental BiologyBone Morphogenic ProteinSclerosteosis Gene	2004	85
Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus May Kung Sutherland, L. Wong, Martin J. Somerville, Molecular Brain Research Alzheimer's DiseaseCalbindin-28k Mrna LevelsDementiaDegenerative PathologyNeurochemical Biomarkers	1993	47
Carboxyl-terminal parathyroid hormone peptide (53–84) elevates alkaline phosphatase and osteocalcin mRNA levels in SaOS-2 cells May Kung Sutherland, L.G. Rao, John N. Wylie, Journal of Bone and Mineral Research	1994	47
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models. Helen Brady, Sonal J. Desai, Leah M. Gayo‐Fung, PubMed Breast OncologyOncologyMedicineXenograft ModelsBreast Cancer Cells	2002	45

Page 1